Global and China Oncology Based In-vivo CRO Market 2020 by Company, Type and Application, Forecast to 2025
Market Overview
The global Oncology Based In-vivo CRO market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 889.4 million by 2025, from USD 750.4 million in 2019.
The Oncology Based In-vivo CRO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Oncology Based In-vivo CRO market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Oncology Based In-vivo CRO market has been segmented into Blood cancer, Solid tumors, Other, etc.
Breakdown by Application, Oncology Based In-vivo CRO has been segmented into Hospitals, Rehabilitation Centers, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncology Based In-vivo CRO market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncology Based In-vivo CRO markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncology Based In-vivo CRO market.
For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Oncology Based In-vivo CRO Market Share Analysis
Oncology Based In-vivo CRO competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Oncology Based In-vivo CRO revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncology Based In-vivo CRO revenue and market share for each player covered in this report.
The major players covered in Oncology Based In-vivo CRO are: Crown Bioscience, The Jackson Laboratory, Eurofins Scientific, Charles River Laboratory, EVOTEC, ICON Plc., MI Bioresearch, Inc., Covance, Taconic Biosciences, Wuxi AppTec., Living Tumor Laboratory, Champion Oncology, Inc., Xentech, etc. Among other players domestic and global, Oncology Based In-vivo CRO market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market segment by players, this report covers
Crown Bioscience
The Jackson Laboratory
Eurofins Scientific
Charles River Laboratory
EVOTEC
ICON Plc.
MI Bioresearch, Inc.
Covance
Taconic Biosciences
Wuxi AppTec.
Living Tumor Laboratory
Champion Oncology, Inc.
Xentech
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)
Market segment by Type, covers:
Blood cancer
Solid tumors
Other
Market segment by Application, can be divided into
Hospitals
Rehabilitation Centers
Others
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Market Overview
- 1.1 Product Overview and Scope of Oncology Based In-vivo CRO
- 1.2 Classification of Oncology Based In-vivo CRO by Type
- 1.2.1 Overview: Global Oncology Based In-vivo CRO Revenue by Type: 2015 Versus 2019 Versus 2025
- 1.2.2 Global Oncology Based In-vivo CRO Revenue Market Share by Type in 2019
- 1.2.3 Blood cancer
- 1.2.4 Solid tumors
- 1.2.5 Other
- 1.3 Global Oncology Based In-vivo CRO Market by Application
- 1.3.1 Overview: Global Oncology Based In-vivo CRO Revenue by Application: 2015 Versus 2019 Versus 2025
- 1.3.2 Hospitals
- 1.3.3 Rehabilitation Centers
- 1.3.4 Others
- 1.4 Global Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 1.5 Global Oncology Based In-vivo CRO Market Size by Regions: 2015 VS 2019 VS 2025
- 1.6 Global Oncology Based In-vivo CRO Market Size by Regions (2015-2020)
- 1.7 Global Oncology Based In-vivo CRO Market Size and Forecast by Regions (2020-2025)
- 1.7.1 North America Oncology Based In-vivo CRO Status and Prospect (2015-2025)
- 1.7.2 Europe Oncology Based In-vivo CRO Status and Prospect (2015-2025)
- 1.7.3 Asia Oncology Based In-vivo CRO Status and Prospect (2015-2025)
- 1.7.4 South America Oncology Based In-vivo CRO Status and Prospect (2015-2025)
- 1.7.5 Middle East & Africa Oncology Based In-vivo CRO Status and Prospect (2015-2025)
- 2 Company Profiles
- 2.1 Crown Bioscience
- 2.1.1 Crown Bioscience Details
- 2.1.2 Crown Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
- 2.1.3 Crown Bioscience SWOT Analysis
- 2.1.4 Crown Bioscience Product and Services
- 2.1.5 Crown Bioscience Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
- 2.2 The Jackson Laboratory
- 2.2.1 The Jackson Laboratory Details
- 2.2.2 The Jackson Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
- 2.2.3 The Jackson Laboratory SWOT Analysis
- 2.2.4 The Jackson Laboratory Product and Services
- 2.2.5 The Jackson Laboratory Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
- 2.3 Eurofins Scientific
- 2.3.1 Eurofins Scientific Details
- 2.3.2 Eurofins Scientific Major Business and Total Revenue (Financial Highlights) Analysis
- 2.3.3 Eurofins Scientific SWOT Analysis
- 2.3.4 Eurofins Scientific Product and Services
- 2.3.5 Eurofins Scientific Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
- 2.4 Charles River Laboratory
- 2.4.1 Charles River Laboratory Details
- 2.4.2 Charles River Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
- 2.4.3 Charles River Laboratory SWOT Analysis
- 2.4.4 Charles River Laboratory Product and Services
- 2.4.5 Charles River Laboratory Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
- 2.5 EVOTEC
- 2.5.1 EVOTEC Details
- 2.5.2 EVOTEC Major Business and Total Revenue (Financial Highlights) Analysis
- 2.5.3 EVOTEC SWOT Analysis
- 2.5.4 EVOTEC Product and Services
- 2.5.5 EVOTEC Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
- 2.6 ICON Plc.
- 2.6.1 ICON Plc. Details
- 2.6.2 ICON Plc. Major Business and Total Revenue (Financial Highlights) Analysis
- 2.6.3 ICON Plc. SWOT Analysis
- 2.6.4 ICON Plc. Product and Services
- 2.6.5 ICON Plc. Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
- 2.7 MI Bioresearch, Inc.
- 2.7.1 MI Bioresearch, Inc. Details
- 2.7.2 MI Bioresearch, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
- 2.7.3 MI Bioresearch, Inc. SWOT Analysis
- 2.7.4 MI Bioresearch, Inc. Product and Services
- 2.7.5 MI Bioresearch, Inc. Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
- 2.8 Covance
- 2.8.1 Covance Details
- 2.8.2 Covance Major Business and Total Revenue (Financial Highlights) Analysis
- 2.8.3 Covance SWOT Analysis
- 2.8.4 Covance Product and Services
- 2.8.5 Covance Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
- 2.9 Taconic Biosciences
- 2.9.1 Taconic Biosciences Details
- 2.9.2 Taconic Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
- 2.9.3 Taconic Biosciences SWOT Analysis
- 2.9.4 Taconic Biosciences Product and Services
- 2.9.5 Taconic Biosciences Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
- 2.10 Wuxi AppTec.
- 2.10.1 Wuxi AppTec. Details
- 2.10.2 Wuxi AppTec. Major Business and Total Revenue (Financial Highlights) Analysis
- 2.10.3 Wuxi AppTec. SWOT Analysis
- 2.10.4 Wuxi AppTec. Product and Services
- 2.10.5 Wuxi AppTec. Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
- 2.11 Living Tumor Laboratory
- 2.11.1 Living Tumor Laboratory Details
- 2.11.2 Living Tumor Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
- 2.11.3 Living Tumor Laboratory SWOT Analysis
- 2.11.4 Living Tumor Laboratory Product and Services
- 2.11.5 Living Tumor Laboratory Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
- 2.12 Champion Oncology, Inc.
- 2.12.1 Champion Oncology, Inc. Details
- 2.12.2 Champion Oncology, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
- 2.12.3 Champion Oncology, Inc. SWOT Analysis
- 2.12.4 Champion Oncology, Inc. Product and Services
- 2.12.5 Champion Oncology, Inc. Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
- 2.13 Xentech
- 2.13.1 Xentech Details
- 2.13.2 Xentech Major Business and Total Revenue (Financial Highlights) Analysis
- 2.13.3 Xentech SWOT Analysis
- 2.13.4 Xentech Product and Services
- 2.13.5 Xentech Oncology Based In-vivo CRO Revenue, Gross Margin and Market Share (2018-2019)
- 3 Market Competition, by Players
- 3.1 Global Oncology Based In-vivo CRO Market Size by Players (2015-2020)
- 3.2 China Oncology Based In-vivo CRO Market Size by Players (2015-2020)
- 3.3 Market Concentration Rate
- 3.3.1 Top 5 Oncology Based In-vivo CRO Players Market Share
- 3.3.2 Top 10 Oncology Based In-vivo CRO Players Market Share
- 4 North America Market Size and Forecast by Countries
- 4.1 North America Oncology Based In-vivo CRO Market Size by Countries (2015-2020)
- 4.2 North America Oncology Based In-vivo CRO Market Size and Forecast by Countries (2015-2026)
- 4.3 United States Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 4.4 Canada Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 4.5 Mexico Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 5 Europe Market Size and Forecast by Countries
- 5.1 Europe Oncology Based In-vivo CRO Market Size by Countries (2015-2020)
- 5.2 Europe Oncology Based In-vivo CRO Market Size and Forecast by Countries (2015-2026)
- 5.3 Germany Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 5.4 France Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 5.5 UK Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 5.6 Russia Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 5.7 Italy Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 6 Asia-Pacific Market Size and Forecast by Countries
- 6.1 Asia-Pacific Oncology Based In-vivo CRO Market Size by Regions (2015-2020)
- 6.2 Asia-Pacific Oncology Based In-vivo CRO Market Size and Forecast by Regions (2015-2026)
- 6.3 China Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 6.4 Japan Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 6.5 Korea Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 6.6 India Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 6.7 Southeast Asia Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 7 South America Market Size and Forecast by Countries
- 7.1 South America Oncology Based In-vivo CRO Market Size by Countries (2015-2020)
- 7.2 South America Oncology Based In-vivo CRO Market Size and Forecast by Countries (2015-2026)
- 7.3 Brazil Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 7.4 Argentina Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 8 Middle East & Africa Market Size and Forecast by Countries
- 8.1 Middle East & Africa Oncology Based In-vivo CRO Revenue by Regions (2015-2020)
- 8.2 Middle East & Africa Oncology Based In-vivo CRO Market Size and Forecast by Countries (2015-2026)
- 8.3 Saudi Arabia Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 8.4 UAE Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 8.5 Egypt Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 8.6 South Africa Oncology Based In-vivo CRO Market Size and Forecast (2015-2025)
- 9 Market Size Segment by Type
- 9.1 Global Oncology Based In-vivo CRO Market Size and Forecast by Type (2015-2025)
- 9.1.1 Global Oncology Based In-vivo CRO Market Size by Type (2015-2020)
- 9.1.2 Global Oncology Based In-vivo CRO Market Size Forecast by Type (2020-2025)
- 9.2 China Oncology Based In-vivo CRO Market Size and Forecast by Type (2015-2025)
- 9.2.1 China Oncology Based In-vivo CRO Market Size by Type (2015-2020)
- 9.2.2 China Oncology Based In-vivo CRO Market Size Forecast by Type (2020-2025)
- 10 Market Size Segment by Application
- 10.1 Global Oncology Based In-vivo CRO Market Size and Forecast by Application (2015-2025)
- 10.1.1 Global Oncology Based In-vivo CRO Market Size by Application (2015-2020)
- 10.1.2 Global Oncology Based In-vivo CRO Market Size Forecast by Application (2020-2025)
- 10.2 China Oncology Based In-vivo CRO Market Size and Forecast by Application (2015-2025)
- 10.2.1 China Oncology Based In-vivo CRO Market Size by Application (2015-2020)
- 10.2.2 China Oncology Based In-vivo CRO Market Size Forecast by Application (2020-2025)
- 11 Research Findings and Conclusion
- 12 Appendix
- 12.1 Methodology
- 12.2 Data Source
- 12.3 Disclaimer
- 12.4 About US
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook